Enhancing the efforts of advocacy
We work with partners globally to strengthen advocacy around disease prevention.
Stopping pandemics before they strike: What you need to know about the Coalition for Epidemic Preparedness Innovations
Johnson & Johnson’s Chief Medical Officer for Global Public Health had a front row seat at the World Economic Forum this year as part of a new coalition aimed at helping to advance vaccine development for pathogens.
“I was on the ground during the HIV epidemic": Meet the scientist who’s sharing the spotlight with celebs at the Global Citizen Festival
It isn’t just music superstars who attend the annual event taking place in New York City and South Africa this year. Johnson & Johnson’s Chief Scientific Officer, Dr. Paul Stoffels, is on the lineup, too. He shares his personal story of why he’s so dedicated to global public health—and how the company is working to prevent HIV infections through an investigational vaccine.
Johnson & Johnson Partners with Save the Children to Help Millions of Children over the Next Three Years
Save the Children named as Enterprise Wide Global Partner
More from Johnson & Johnson
Giving the gift of sight
In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.
Meet a nurse who leads clinical trials to find innovative cancer therapies
Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.
3 health advocates; 1 Johnson & Johnson program that offers empowerment and connection
In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.